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Background 
Chronic inflammation has been associated with the onset of depression, but the mechanisms 
underlying this relationship remain elusive.  This study examined whether sleep explained the 
association between elevated levels of inflammatory markers and subsequent depressive symptoms 
in an English nationally representative sample. 
Methods 
The sample consisted of 2,953 men and women (aged 50+) recruited from the English Longitudinal 
Study of Ageing (ELSA) an ongoing, open, representative prospective cohort study.  Four waves of 
data between 2008/09 (wave 4) and 2016/17 (wave 8) were analysed.  Serum levels of inflammatory 
markers (CRP, fibrinogen) and covariates (age, sex, education, wealth, body mass index, smoking, 
cholesterol, triglyceride) were measured at wave 4 (considered here as the baseline).  Self-reported 
sleep disturbance (versus no sleep disturbance) was examined via three items of the Jenkins Sleep 
Problems Scale (difficulty falling asleep, trouble remaining asleep and morning tiredness) at a four-
year follow-up (wave 6, 2012/13).  Depressive symptoms were assessed at baseline and six years 
later (wave 7, 2014/15) using the 8-item version of the Centre for Epidemiological Studies 
Depression Scale (CES-D) (excl. item on sleep). Binary mediation analysis was used to investigate 
whether sleep mediated the relationship between systemic inflammation and depressive symptoms, 
adjusting for the full set of covariates.  
Results 
High baseline levels of CRP were significantly associated with greater odds of subsequent depressive 
symptoms, independent of age, sex and baseline depressive symptoms (Odds Ratio (OR)=1.32  (95% 
Confidence Intervals (CI)) 1.02-1.70). Further adjustment for socio-economic variables (education, 
wealth status) attenuated this relationship to non-significance (OR=1.17 (95% CI) 0.90-1.53). High 
CRP levels at baseline were significantly related to higher odds of reporting sleep disturbance at 
wave 6 (OR: 1.44; (95% CI) 1.14-1.82).  Sleep disturbance was associated with greater odds of 
subsequent depressive symptoms (OR: 2.69 (95% CI) 2.03-3.57).  Mediation analyses revealed that 
sleep problems mediated the relationship between high CRP and depressive symptoms, explaining a 
total of 65.61% of this association. 
Conclusions: 
In this nationally representative sample, we found that sleep disturbance is a partial mediator of the 
relationship between high CRP and subsequent depressive symptoms.  Interventions targeting sleep 
disturbance may be effective in ameliorating inflammation-associated depressive symptoms. 
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